Viruses That Can and Cannot Coexist With Humans and the Future of SARS-CoV-2

被引:18
|
作者
Furuse, Yuki [1 ,2 ]
Oshitani, Hitoshi [3 ]
机构
[1] Kyoto Univ, Inst Frontier Life & Med Sci, Kyoto, Japan
[2] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto, Japan
[3] Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi, Japan
关键词
COVID-19; SARS-CoV-2; epidemiology; transmission; zoonosis; evolution; TRANSMISSION DYNAMICS; MEASLES-VIRUS; INFLUENZA; EVOLUTION; COVID-19; IMMUNITY; ECOLOGY; SARS; EPIDEMIOLOGY; DETERMINANTS;
D O I
10.3389/fmicb.2020.583252
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a worldwide pandemic. Many projections concerning the outbreak, such as the estimated number of cases and deaths in upcoming months, have been made available. However, what happens to the virus after the pandemic subsides has not been fully explored. In this article, we discuss the ways that past and present human viruses have emerged via zoonotic transmission, the mechanisms that they have acquired the ability for effective transmission among humans, the process to sustain a chain of transmission to coexist with humans, and the factors important for complete containment leading to eradication of viruses. These aspects of viral disease may provide clues for the future path that SARS-CoV-2 might take in relation to human infection.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Amniocentesis and SARS-CoV-2, in the light of the experience with other viruses
    Massarotti, Claudia
    di Marco, Eddi
    Gaggero, Chiara Roberta
    Molinari, Chiara
    Cagnacci, Angelo
    de Biasio, Pierangela
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2022, 35 (25): : 5069 - 5070
  • [42] Ethanol Susceptibility of SARS-CoV-2 and Other Enveloped Viruses
    Nomura, Toshihito
    Nazmul, Tanuza
    Yoshimoto, Reiko
    Higashiura, Akifumi
    Oda, Kosuke
    Sakaguchi, Takemasa
    BIOCONTROL SCIENCE, 2021, 26 (03) : 177 - 180
  • [43] Lipids, statins and susceptibility to SARS-CoV-2 and influenza A viruses
    Carabott, Melissa
    Case, Ryan
    Dhakal, Sudip
    Macreadie, Ian
    MICROBIOLOGY AUSTRALIA, 2021, 42 (02) : 87 - 91
  • [44] SARS-CoV-2 and other viruses in soil: An environmental outlook
    Anand, Uttpal
    Bianco, Francesco
    Suresh, S.
    Tripathi, Vijay
    Nunez-Delgado, Avelino
    Race, Marco
    ENVIRONMENTAL RESEARCH, 2021, 198
  • [45] SARS-CoV-2 viruses change epigenetic regulatory processes
    Simon, Annika
    PNEUMOLOGIE, 2023, 77 (01): : 14 - 14
  • [46] Admission diagnostics for SARS-CoV-2 and other respiratory viruses
    Cimolai, Nevio
    ACTA PAEDIATRICA, 2024, 113 (07) : 1732 - 1733
  • [47] Influenza viruses and SARS-CoV-2 in adult: 'Similarities and differences'
    Torun, Serife
    Kesim, Cagri
    Suner, Aynur
    Botan Yildirim, Berna
    Ozen, Ozgur
    Akcay, Sule
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2021, 69 (04): : 458 - 468
  • [48] Natural molecules having anti-SARS- CoV activity - cannot they be effective against SARS-CoV-2?
    Semwal, Deepak Kumar
    Chauhan, Ashutosh
    Semwal, Ruchi Badoni
    Sircar, Debabrata
    Roy, Partha
    Lehmann, Jorg
    CURRENT SCIENCE, 2020, 119 (05): : 757 - 770
  • [49] Can SARS-coV-2 trigger a food allergy?
    Fernandes, I. F.
    Cunha, L.
    ALLERGY, 2021, 76 : 359 - 360
  • [50] Fluoxetine Can Inhibit SARS-CoV-2 In Vitro
    Dechaumes, Arthur
    Nekoua, Magloire Pandoua
    Belouzard, Sandrine
    Sane, Famara
    Engelmann, Ilka
    Dubuisson, Jean
    Alidjinou, Enagnon Kazali
    Hober, Didier
    MICROORGANISMS, 2021, 9 (02) : 1 - 10